insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

BYSI · Beyondspring Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · BYSI

1Y3Y5YMax
Sign in to download
AnnualQuarterly

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22
Revenue----------
Cost of Revenue----------
Gross Profit----------
R&D$1.08M-$622.0K$1.00M$721.0K-----
SG&A$1.16M-$751.0K$947.0K$1.33M-----
Total Operating Expenses----------
D&A$19.0K---$67.0K-----
Operating Income($2.23M)-($1.79M)($1.95M)($2.06M)-----
Interest Expense----------
Income Tax$192.0K-$26.0K$0$0-----
Net Income($2.16M)-($1.54M)($1.81M)($3.23M)-----
EPS - Basic($0.05)-($0.04)($0.10)($0.08)-----
EPS - Diluted---($0.04)------

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22
Cash & Equivalents$4.04M$7.79M$12.48M$9.54M$6.53M$2.92M$7.81M$15.34M$13.49M$34.40M
Accounts Receivable----------
Inventory----------
Accounts Payable$646.0K$363.0K$304.0K$266.0K$358.0K$295.0K$1.41M-$1.50M$1.08M
Current Assets$13.50M$20.88M$24.41M$25.71M$31.53M$28.58M$18.42M-$25.79M$38.52M
Total Assets$18.41M$25.93M$29.48M$31.04M$37.10M$34.31M$24.81M-$32.88M$46.22M
Current Liabilities$12.37M$13.58M$12.89M$11.73M$12.66M$11.01M$7.96M-$6.82M$7.35M
Long-term Debt----------
Total Liabilities$48.76M$49.92M$49.29M$48.59M$49.77M$48.60M$47.17M-$47.56M$49.23M
Stockholders' Equity($34.49M)($32.16M)($31.77M)($30.22M)($28.31M)($32.90M)($26.80M)-($18.09M)($5.98M)
Retained Earnings($410.59M)($408.43M)($406.29M)($404.75M)($402.95M)($407.43M)($396.30M)-($388.00M)($375.28M)

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22
Operating Cash Flow($3.28M)---($5.27M)-----
Investing Cash Flow$4.48M---$0-----
Financing Cash Flow$0---------
CapEx$0---$0-----
Free Cash Flow($3.28M)---($5.27M)-----

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q2 '24Q4 '23Q2 '23Q4 '22
Profitability
Gross margin----------
Operating margin----------
EBITDA margin----------
Net margin----------
Free cash flow margin----------
FCF / Net income1.52---1.63-----
R&D / Revenue----------
SG&A / Revenue----------
Effective tax rate----------
Return on assets-11.7%--5.2%-5.8%-8.7%-----
Return on equity6.3%-4.8%6.0%11.4%-----
Return on invested capital----------
Liquidity
Current ratio1.091.541.892.192.492.602.31-3.785.24
Quick ratio1.091.541.892.192.492.602.31-3.785.24
Cash ratio0.330.570.970.810.520.270.98-1.984.68
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage----------
Equity multiplier-0.53-0.81-0.93-1.03-1.31-1.04-0.93--1.82-7.73
Liabilities / Assets2.651.931.671.571.341.421.90-1.451.07
Efficiency
Asset turnover----------
Inventory turnover----------
Days sales outstanding----------
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E----------
P / B----------
P / S----------
EV / EBITDA----------
Growth
Revenue growth (YoY)----------
Revenue CAGR (3y)----------
Revenue CAGR (5y)----------
Gross profit growth (YoY)----------
Operating income growth (YoY)-8.6%---------
Net income growth (YoY)33.2%---------
EPS growth (YoY)----------
EPS CAGR (3y)----------
EPS CAGR (5y)----------
FCF growth (YoY)37.8%---------
FCF CAGR (5y)----------
Book value growth (YoY)-21.8%2.2%--12.7%---48.2%---

Peer comparison

Same SIC group: Pharmaceutical Preparations

CompanyRevenue (last FY)Net marginROE
LLY$65.18B31.7%77.8%
UTHR$3.18B41.9%18.8%
PFE$62.58B12.4%9.0%
ZTS$9.47B28.2%80.2%
VRTX$12.00B32.9%21.2%

Comparing BeyondSpring Inc. against the 5 most active filers in the same SIC group.